HighTower Advisors, LLC - FINCH THERAPEUTICS GROUP INC ownership

FINCH THERAPEUTICS GROUP INC's ticker is FNCH and the CUSIP is 31773D101. A total of 1 filers reported holding FINCH THERAPEUTICS GROUP INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 1.3%.

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of FINCH THERAPEUTICS GROUP INC
ValueSharesWeighting
Q1 2023$5,000
-16.7%
13,831
-2.1%
0.00%
Q4 2022$6,000
-72.7%
14,1310.0%0.00%
Q3 2022$22,000
-63.9%
14,131
-33.0%
0.00%
Q2 2022$61,000
-33.0%
21,099
+16.6%
0.00%
Q1 2022$91,000
-49.4%
18,0990.0%0.00%
Q4 2021$180,000
-24.1%
18,0990.0%0.00%
-100.0%
Q3 2021$237,000
+12.9%
18,099
+21.6%
0.00%0.0%
Q2 2021$210,000
+16.0%
14,888
+32.7%
0.00%0.0%
Q1 2021$181,00011,2180.00%
Other shareholders
FINCH THERAPEUTICS GROUP INC shareholders Q2 2023
NameSharesValueWeighting ↓
TRB Advisors LP 550,000$7,739,0001.75%
Bleichroeder LP 810,416$11,403,0001.72%
Aperture Investors, LLC 319,122$4,490,0000.51%
Ikarian Capital, LLC 325,000$4,573,0000.37%
SECTORAL ASSET MANAGEMENT INC 300,399$4,227,0000.34%
Baupost Group 1,208,159$16,693,0000.14%
Proficio Capital Partners LLC 112,059$1,577,0000.12%
LIGHT STREET CAPITAL MANAGEMENT, LLC 168,330$2,368,0000.10%
MSD Partners, L.P. 235,294$3,311,0000.09%
PURA VIDA INVESTMENTS, LLC 71,552$1,007,0000.03%
View complete list of FINCH THERAPEUTICS GROUP INC shareholders